NCT03507829View on ClinicalTrials.gov

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

PHASE3CompletedINTERVENTIONAL
Enrollment

263

Participants

Timeline

Start Date

November 21, 2012

Primary Completion Date

May 22, 2018

Study Completion Date

May 22, 2018

Conditions
Hyperglycemia
Interventions
DRUG

Human insulin isophane, Humulin N (Eli Lilly)

Human insulin isophane, Humulin N (Eli Lilly)

DRUG

Standard of care

Sliding scale short acting insulin for hyperglycemia; Sulphonylurea for NODAT

DRUG

Insulin lispro, Humalog (Eli Lilly) in insulin pump

Insulin lispro, Humalog (Eli Lilly) in insulin pump

All Listed Sponsors
collaborator

Charite University, Berlin, Germany

OTHER

collaborator

Medical University of Graz

OTHER

collaborator

Hospital del Mar

OTHER

lead

Medical University of Vienna

OTHER

NCT03507829 - Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients | Biotech Hunter | Biotech Hunter